Limsan, Irene Rose P.

HRN: 05-19-33  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/17/2022
CEFUROXIME 500MG (TAB)
06/17/2022
06/23/2022
PO
500mg
BID X 7 Days
WBC: 23.8; S/p NSVD, Transient Uterine Atony
Waiting Final Action 
06/17/2022
METRONIDAZOLE 500MG (TAB)
06/17/2022
06/23/2022
PO
500mg
TID X 7 Days
WBC: 23.8; S/p NSVD, Transient Uterine Atony
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: